Page last updated: 2024-09-04

docetaxel anhydrous and betadex

docetaxel anhydrous has been researched along with betadex in 20 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(betadex)
Trials
(betadex)
Recent Studies (post-2010) (betadex)
12,1103,2166,9208,785974,452

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.00)18.2507
2000's1 (5.00)29.6817
2010's17 (85.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Bressolle, F; Grosse, PY; Pinguet, F1
Baussanne, I; Benito, JM; Defaye, J; García Fernández, JM; Gómez-García, M; Ortiz Mellet, C1
Chen, C; Huang, XX; Ren, Y; Wang, H; Xu, Q; Yu, SQ; Zhou, CL; Zhu, YY1
Bouchemal, K; Cheron, M; Gallard, JF; Gueutin, C; Iorga, BI; Mazzaferro, S; Ponchel, G; Steinmesse, C1
Kim, EJ; Kim, TK; Lee, BY; Park, JH; Yoo, HH1
Fang, L; Shen, Q; Wu, J1
Kim, IS; Kim, TK; Yoo, HH1
Bouchemal, K; Chacun, H; Gueutin, C; Mazzaferro, S; Ponchel, G; Skanji, R1
Kim, EJ; Kim, TK; Lee, BY; Park, JH; Sa, JH; Yoo, HH1
Arra, C; Barbieri, A; Bimonte, S; Conte, C; Luciano, A; Palma, G; Quaglia, F; Rea, D; Tirino, P; Ungaro, F1
Fan, Y; Huang, X; Liang, Z; Pan, J; Yi, C; Zhang, Y; Zhao, L1
Bansal, S; Ferrati, S; Grattoni, A; Hosali, S; Landis, M; Nicolov, E1
Chen, K; Gong, H; Guo, J; Han, S; Li, X; Wei, Y; Zhang, D; Zhang, J1
Bu, X; Dou, L; Fang, L; Shen, Q; Wu, J1
Jiang, G; Liu, F; Liu, T; Wang, W; Wang, Y; Wu, T; Wu, X; Xie, M; Zhang, T1
Belaaloui, G; Jiang, ZZ; Khaled, M; Zhang, LY; Zhu, X1
Hu, Q; Kirk, TB; Ma, D; Tang, Q; Wu, J; Xu, J; Xu, Z; Xue, W; Zhang, Y1
Hou, X; Jiang, G; Liu, T; Wang, Y; Wu, T; Wu, X; Xie, H; Xie, M1
Feng, Z; He, L; Huang, J; Li, B; Li, W; Liu, J; Ma, Y; Wang, K; Wang, Q; Yang, X; Zheng, Y1
Chaudhari, D; Desai, MR; Jain, S; Katiyar, SS; Kuche, K; Nallamothu, B1

Other Studies

20 other study(ies) available for docetaxel anhydrous and betadex

ArticleYear
In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Cisplatin; Cyclodextrins; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluorouracil; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ovarian Neoplasms; Paclitaxel; Taxoids; Tumor Cells, Cultured

1998
Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates.
    Journal of the American Chemical Society, 2004, Aug-25, Volume: 126, Issue:33

    Topics: beta-Cyclodextrins; Concanavalin A; Cyclodextrins; Docetaxel; Drug Carriers; Humans; Lectins; Lectins, C-Type; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Oligosaccharides; Paclitaxel; Receptors, Cell Surface; Taxoids

2004
Pharmacokinetics, efficacy, and safety evaluation of docetaxel/hydroxypropyl-sulfobutyl-β-cyclodextrin inclusion complex.
    AAPS PharmSciTech, 2011, Volume: 12, Issue:2

    Topics: Animals; beta-Cyclodextrins; Docetaxel; Drug Delivery Systems; HCT116 Cells; Hep G2 Cells; Humans; Male; Mice; Neoplasms; Rabbits; Random Allocation; Rats; Rats, Wistar; Taxoids; Treatment Outcome; Xenograft Model Antitumor Assays

2011
Bivalent sequential binding of docetaxel to methyl-β-cyclodextrin.
    International journal of pharmaceutics, 2011, Sep-15, Volume: 416, Issue:1

    Topics: beta-Cyclodextrins; Chemistry, Pharmaceutical; Circular Dichroism; Cyclodextrins; Docetaxel; Entropy; Models, Molecular; Molecular Structure; Solubility; Taxoids

2011
Pharmacokinetic equivalence of Taxotere and SID530, a novel docetaxel formulation containing hydroxypropyl-beta-cyclodextrin in monkeys.
    Arzneimittel-Forschung, 2012, Volume: 62, Issue:6

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; beta-Cyclodextrins; Calibration; Chemistry, Pharmaceutical; Docetaxel; Excipients; Macaca fascicularis; Male; Reference Standards; Tandem Mass Spectrometry; Taxoids; Therapeutic Equivalency

2012
Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
    Drug development and industrial pharmacy, 2013, Volume: 39, Issue:7

    Topics: Administration, Oral; Animals; Antineoplastic Agents; beta-Cyclodextrins; Biological Availability; Chitosan; Docetaxel; Drug Delivery Systems; Male; Nanoparticles; Permeability; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Taxoids; X-Ray Diffraction

2013
Determination of docetaxel in rat plasma and its application in the comparative pharmacokinetics of Taxotere and SID530, a novel docetaxel formulation with hydroxypropyl-β-cyclodextrin.
    Biomedical chromatography : BMC, 2013, Volume: 27, Issue:3

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Area Under Curve; beta-Cyclodextrins; Chromatography, Liquid; Docetaxel; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids

2013
Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Sep-28, Volume: 162, Issue:3

    Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Chitosan; Cyanoacrylates; Docetaxel; Enbucrilate; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Nanoparticles; Pancreatin; Permeability; Rats; Rats, Wistar; Taxoids

2012
Comparative protein binding of taxotere and SID530, a new docetaxel formulation with hydroxypropyl-beta-cyclodextrin, in human plasma in vitro.
    Die Pharmazie, 2012, Volume: 67, Issue:9

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Blood Proteins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dialysis; Docetaxel; Humans; Indicators and Reagents; Mass Spectrometry; Powders; Protein Binding; Reproducibility of Results; Taxoids; Therapeutic Equivalency

2012
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
    International journal of pharmaceutics, 2014, Oct-01, Volume: 473, Issue:1-2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Blood Proteins; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Docetaxel; Ethylene Glycols; Female; Humans; Mammary Neoplasms, Experimental; Mice, Nude; Nanoparticles; Polyesters; Powders; Taxoids; Triple Negative Breast Neoplasms; Tumor Burden

2014
Magnetic Fe₃ O ₄ nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy.
    Materials science & engineering. C, Materials for biological applications, 2014, Volume: 42

    Topics: Antigens, CD; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Docetaxel; Drug Carriers; Endoglin; Female; Human Umbilical Vein Endothelial Cells; Humans; Magnetite Nanoparticles; Ovarian Neoplasms; Receptors, Cell Surface; Single-Chain Antibodies; Taxoids

2014
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
    Current drug targets, 2015, Volume: 16, Issue:14

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Female; Humans; Mice; Mice, SCID; Taxoids; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2015
Engineering of Biocompatible pH-Responsive Nanovehicles from Acetalated Cyclodextrins as Effective Delivery Systems for Tumor Therapy.
    Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:6

    Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Biocompatible Materials; Cells, Cultured; Docetaxel; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polymers; Taxoids

2015
Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities.
    Journal of biomedical nanotechnology, 2015, Volume: 11, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; beta-Cyclodextrins; Biological Availability; Cell Survival; Chitosan; Diffusion; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Male; MCF-7 Cells; Mice; Nanocapsules; Neoplasms, Experimental; Rats; Rats, Wistar; Taxoids

2015
Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
    Oncotarget, 2016, Jul-05, Volume: 7, Issue:27

    Topics: Animals; Apoptosis; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Folic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Tissue Distribution; Transfection

2016
Antitumor effect of Deoxypodophyllotoxin on human breast cancer xenograft transplanted in BALB/c nude mice model.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:10

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drugs, Chinese Herbal; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Podophyllotoxin; Taxoids; Xenograft Model Antitumor Assays

2016
Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery.
    Materials science & engineering. C, Materials for biological applications, 2017, Feb-01, Volume: 71

    Topics: Adenocarcinoma; beta-Cyclodextrins; Breast Neoplasms; Cell Line; Delayed-Action Preparations; Docetaxel; Drug Screening Assays, Antitumor; Erythrocytes; Female; Glycerol; Hemolysis; Humans; Polymers; Taxoids

2017
CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Animals; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Carriers; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Transplantation, Heterologous

2017
Self-Assembled Supramolecular Nanoparticles for Targeted Delivery and Combination Chemotherapy.
    ChemMedChem, 2018, 10-08, Volume: 13, Issue:19

    Topics: Antineoplastic Agents; Aptamers, Nucleotide; Base Sequence; beta-Cyclodextrins; Cell Line, Tumor; DNA; Docetaxel; Doxorubicin; Drug Carriers; Drug Combinations; Drug Synergism; Humans; Nanoparticles; Propylene Glycols; Theranostic Nanomedicine

2018
Partial inclusion complex assisted crosslinked β-cyclodextrin nanoparticles for improving therapeutic potential of docetaxel against breast cancer.
    Drug delivery and translational research, 2022, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Humans; Nanoparticles

2022
chemdatabank.com